13F Data
13F filer · CIK 1056807

BVF INC/IL

San Francisco, CA · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$3.9B
+$772.0M vs prior
Positions
44
New / sold out
7 / 4
Added / reduced
6 / 8
Turnover
10.2%
buys $360.8M · sells $421.1M
Top-10 weight
65.6%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedXOMA ROYALTY CORPORATION+5,003,000+193.1%+$212.6M
NewQ32 BIO INC+2,350,000–+$29.9M
NewABSCI CORPORATION+2,361,674–+$27.4M
AddedREVOLUTION MEDICINES INC+108,378+3.8%+$20.3M
NewSAGIMET BIOSCIENCES INC+2,500,000–+$19.3M
NewIMMUNIC INC+765,295–+$11.8M
AddedAVALO THERAPEUTICS INC+442,700+27.1%+$8.2M
AddedALKERMES PLC+154,704+7.7%+$8.1M
AddedINVIVYD INC+8,640,000+44.3%+$7.5M
AddedONKURE THERAPEUTICS INC+1,256,806+63.5%+$5.7M
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedKYMERA THERAPEUTICS INC-1,630,658-29.6%$-187.0M
ReducedMIRUM PHARMACEUTICALS INC-528,700-33.4%$-61.9M
ReducedPALVELLA THERAPEUTICS INC NE-288,200-30.0%$-44.0M
Sold outCOMPASS THERAPEUTICS INC-7,764,842-100.0%$-41.1M
Sold outSEPTERNA INC-1,353,249-100.0%$-32.5M
ReducedTYRA BIOSCIENCES INC-500,000-25.3%$-16.0M
ReducedNEKTAR THERAPEUTICS-168,520-6.6%$-11.8M
ReducedDISC MEDICINE INC-118,700-9.3%$-8.7M
Sold outIMMUNIC INC-7,652,972-100.0%$-8.5M
ReducedSTRUCTURE THERAPEUTICS INC-92,535-2.7%$-5.0M
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $515.3MQ3 2013: $581.2MQ4 2013: $571.6MQ1 2014: $645.1MQ2 2014: $632.3MQ3 2014: $481.6MQ4 2014: $514.1MQ1 2015: $478.2MQ2 2015: $566.6MQ3 2015: $495.0MQ4 2015: $586.8MQ1 2016: $404.1MQ2 2016: $469.4MQ3 2016: $530.7MQ4 2016: $497.7MQ1 2017: $587.9MQ2 2017: $644.0MQ3 2017: $786.7MQ4 2017: $829.5MQ1 2018: $986.5MQ2 2018: $1.0BQ3 2018: $1.1BQ4 2018: $765.2MQ1 2019: $893.1MQ2 2019: $915.6MQ3 2019: $951.8MQ4 2019: $1.3BQ1 2020: $1.1BQ2 2020: $1.6BQ3 2020: $1.8BQ4 2020: $2.5BQ1 2021: $2.7BQ2 2021: $2.7BQ3 2021: $2.6BQ4 2021: $2.8BQ1 2022: $2.5BQ2 2022: $2.1BQ3 2022: $2.4BQ4 2022: $2.4BQ1 2023: $2.7BQ2 2023: $3.6BQ3 2023: $3.7BQ4 2023: $4.0BQ1 2024: $3.6BQ2 2024: $3.6BQ3 2024: $3.4BQ4 2024: $3.0BQ1 2025: $2.5BQ2 2025: $2.8BQ3 2025: $2.5BQ4 2025: $3.0BQ1 2026: $3.1BQ2 2026: $3.9B
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1REVOLUTION MEDICINES INCCOM2,965,160$555.3M14.20%
2KYMERA THERAPEUTICS INCCOM3,872,052$444.0M11.35%
3XOMA ROYALTY CORPORATIONCOM NEW7,593,303$322.7M8.25%
4MOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD16,001,284$311.5M7.97%
5GH RESEARCH PLCORDINARY SHARES8,650,158$232.5M5.95%
6STRUCTURE THERAPEUTICS INCSPONSORED ADS3,366,823$180.7M4.62%
7NEKTAR THERAPEUTICSCOM NEW2,391,075$166.9M4.27%
8MIRUM PHARMACEUTICALS INCCOM1,056,027$123.6M3.16%
9XENCOR INCCOM7,133,720$114.9M2.94%
10ALKERMES PLCSHS2,154,704$112.9M2.89%
34 more rows. Subscribe for $29/month to see every row, download the data and use the API.